Krista Morales, MD
Family Medicine · Clifton Park, NYNPI 1679005326
Payments from drug & device makers
Across 310 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$748
- AbbVie$717
- Boehringer Ingelheim$534
- AstraZeneca$389
- Amgen$349
- Lilly USA, LLC$322
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,463100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $748 |
| AbbVie(2 entities) | 49 | $717 |
| Boehringer Ingelheim | 25 | $534 |
| AstraZeneca | 21 | $389 |
| Amgen | 20 | $349 |
| Lilly USA, LLC | 17 | $322 |
| Abbott | 17 | $320 |
| Pfizer | 21 | $309 |
| GSK | 14 | $214 |
| Phathom Pharmaceuticals, Inc. | 8 | $150 |
| Astellas Pharma US Inc | 7 | $147 |
| Biohaven Pharmaceuticals, Inc. | 8 | $142 |
| Merck | 7 | $120 |
| Amarin Pharma, Inc. | 5 | $93 |
| Idorsia Pharmaceuticals US Inc | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $68 |
| Esperion Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Seqirus USA Inc | 3 | $63 |
| Johnson & Johnson | 4 | $61 |
| Sanofi Pasteur Inc. | 3 | $53 |
| Sumitomo Pharma America, Inc. | 4 | $51 |
| UCB, Inc. | 1 | $46 |
| Exact Sciences | 2 | $45 |
| Exeltis, USA Inc. | 2 | $36 |
| IBSA Pharma Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $30 |
| Dynavax Technologies Corporation | 1 | $29 |
| Eisai Inc. | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Gilead | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
How this compares
$5,463 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $89,698 |
| JardianceEmpagliflozin | 48 | $71,103 |
| RybelsusSemaglutide | 16 | $36,443 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $27,330 |
| MounjaroTirzepatide | 22 | $26,174 |
| TrulicityDulaglutide | 11 | $17,481 |
| EliquisApixaban | 26 | $17,186 |
| MyrbetriqMirabegron | 12 | $12,336 |
| Atorvastatin Calcium | 410 | $4,940 |
| Omeprazole | 188 | $3,393 |
| Levothyroxine Sodium | 203 | $3,060 |
| Ezetimibe | 46 | $2,759 |
| Duloxetine Hcl | 70 | $2,462 |
| SynthroidLevothyroxine Sodium | 37 | $2,192 |
| Rosuvastatin Calcium | 108 | $1,755 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $748 | $126,14172 claims |
| Boehringer IngelheimJardiance | $534 | $71,10348 claims |
| Lilly USA, LLCMounjaro, Trulicity | $322 | $43,65533 claims |
| GSKTrelegy Ellipta | $214 | $27,33016 claims |
| PfizerEliquis | $309 | $17,18626 claims |
| Astellas Pharma US IncMyrbetriq | $147 | $12,33612 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $30 | $3,060203 claims |
| AbbVieSynthroid | $717 | $2,19237 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,321 family medicine providers in New York.
Other family medicine in Clifton Park
- Matthew CunninghamClifton Park$189K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.